Literature DB >> 22968172

Determination of optical properties in heterogeneous turbid media using a cylindrical diffusing fiber.

Andreea Dimofte1, Jarod C Finlay, Xing Liang, Timothy C Zhu.   

Abstract

For interstitial photodynamic therapy (PDT), cylindrical diffusing fibers (CDFs) are often used to deliver light. This study examines the feasibility and accuracy of using CDFs to characterize the absorption (μ(a)) and reduced scattering (μ'(s)) coefficients of heterogeneous turbid media. Measurements were performed in tissue-simulating phantoms with μ(a) between 0.1 and 1 cm(-1) and μ'(s) between 3 and 10 cm(-1) with CDFs 2 to 4 cm in length. Optical properties were determined by fitting the measured light fluence rate profiles at a fixed distance from the CDF axis using a heterogeneous kernel model in which the cylindrical diffusing fiber is treated as a series of point sources. The resulting optical properties were compared with independent measurement using a point source method. In a homogenous medium, we are able to determine the absorption coefficient μ(a) using a value of μ'(s) determined a priori (uniform fit) or μ'(s) obtained by fitting (variable fit) with standard (maximum) deviations of 6% (18%) and 18% (44%), respectively. However, the CDF method is found to be insensitive to variations in μ'(s), thus requiring a complementary method such as using a point source for determination of μ'(s). The error for determining μ(a) decreases in very heterogeneous turbid media because of the local absorption extremes. The data acquisition time for obtaining the one-dimensional optical properties distribution is less than 8 s. This method can result in dramatically improved accuracy of light fluence rate calculation for CDFs for prostate PDT in vivo when the same model and geometry is used for forward calculations using the extrapolated tissue optical properties.

Entities:  

Mesh:

Year:  2012        PMID: 22968172      PMCID: PMC3444568          DOI: 10.1088/0031-9155/57/19/6025

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  34 in total

1.  Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media.

Authors:  J P Marijnissen; W M Star
Journal:  Phys Med Biol       Date:  1996-07       Impact factor: 3.609

2.  Three-dimensional optical phantom and its application in photodynamic therapy.

Authors:  R Bays; G Wagnières; D Robert; J F Theumann; A Vitkin; J F Savary; P Monnier; H van den Bergh
Journal:  Lasers Surg Med       Date:  1997       Impact factor: 4.025

Review 3.  Light dosimetry in vivo.

Authors:  W M Star
Journal:  Phys Med Biol       Date:  1997-05       Impact factor: 3.609

4.  An interstitial light assembly for photodynamic therapy in prostatic carcinoma.

Authors:  L K Lee; C Whitehurst; M L Pantelides; J V Moore
Journal:  BJU Int       Date:  1999-11       Impact factor: 5.588

5.  Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.

Authors:  Timothy C Zhu; Andreea Dimofte; Jarod C Finlay; Diana Stripp; Theresa Busch; Jeremy Miles; Richard Whittington; S Bruce Malkowicz; Zelig Tochner; Eli Glatstein; Stephen M Hahn
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

6.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Jarod C Finlay; Stephen M Hahn
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

7.  Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients.

Authors:  Robert A Weersink; Jason Forbes; Stuart Bisland; John Trachtenberg; Mostafa Elhilali; Pierre H Brún; Brian C Wilson
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

8.  In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Stephen M Hahn; Amy S Kapatkin; Andreea Dimofte; Carmen E Rodriguez; Teodor G Vulcan; Eli Glatstein; R Alex Hsi
Journal:  Photochem Photobiol       Date:  2003-01       Impact factor: 3.421

9.  Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.

Authors:  Timothy R Nathan; Douglas E Whitelaw; Stanley C Chang; William R Lees; Paul M Ripley; Heather Payne; Linda Jones; M Constance Parkinson; Mark Emberton; Alison R Gillams; Anthony R Mundy; Stephen G Bown
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

Review 10.  Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.

Authors:  A V D'Amico; C N Coleman
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

View more
  6 in total

1.  Cylindrical diffuser axial detection profile is dependent on fiber design.

Authors:  Timothy M Baran
Journal:  J Biomed Opt       Date:  2015-04       Impact factor: 3.170

2.  Comparison of flat cleaved and cylindrical diffusing fibers as treatment sources for interstitial photodynamic therapy.

Authors:  Timothy M Baran; Thomas H Foster
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

3.  Recovery of optical properties using interstitial cylindrical diffusers as source and detector fibers.

Authors:  Timothy M Baran
Journal:  J Biomed Opt       Date:  2016-07-01       Impact factor: 3.170

4.  In-vivo singlet oxygen threshold doses for PDT.

Authors:  Timothy C Zhu; Michele M Kim; Xing Liang; Jarod C Finlay; Theresa M Busch
Journal:  Photonics Lasers Med       Date:  2015-02

5.  Feasibility of interstitial diffuse optical tomography using cylindrical diffusing fibers for prostate PDT.

Authors:  Xing Liang; Ken Kang-Hsin Wang; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2013-04-30       Impact factor: 3.609

6.  Optimized Cylindrical Diffuser Powers for Interstitial PDT Breast Cancer Treatment Planning: A Simulation Study.

Authors:  Fatimah S Ismael; Hani Amasha; Wesam Bachir
Journal:  Biomed Res Int       Date:  2020-03-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.